XENE

Xenon Pharmaceuticals Inc.

Pharmaceutical Preparations · SIC 2834CIK 1582313Held by 9 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

9 managers · Q2 2026 13F

13F bookWeight

OrbiMed Advisors

OrbiMed AdvisorsPosition history →

1.0%

(15.8%)

$53.9M

$5.25B13F book · 2026-06-30

Deerfield Management Company

Deerfield Management CompanyPosition history →

1.0%

—

$97.5M

$9.59B13F book · 2026-06-30

Duquesne Family Office

Stanley DruckenmillerPosition history →

0.33%

—

$14.4M

$4.35B13F book · 2026-06-30

Baker Bros. Advisors

Baker Bros. AdvisorsPosition history →

0.11%

—

$22.3M

$19.96B13F book · 2026-06-30

Royce & Associates

Royce & AssociatesPosition history →

0.03%

NEW

$3.9M

$12.42B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.03%

+44.1%

$5.9M

$21.33B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.03%

(36.2%)

$18.1M

$71.32B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

0.02%

(37.7%)

$11.3M

$72.62B13F book · 2026-06-30

Capital World Investors

Capital World InvestorsPosition history →

0.01%

+2.7%

$52.1M

$846.43B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.